Yangmin Qiu

The Application of Ferroptosis in Diseases.

N. Lu, Yue Cao, Wangjia Cao, 2020, Pharmacological research.

Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer

N. Lu, Q. Guo, R. Tan, 2018, Journal of Experimental & Clinical Cancer Research.

CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK

N. Lu, K. Zhao, Binyan Lin, 2020, Oncogene.

Cancer immune therapy with PD-1-dependent CD137 co-stimulation provides localized tumour killing without systemic toxicity

M. Zhang, Zhihai Wu, Bingliang Chen, 2021, Nature Communications.

Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis.

N. Lu, Q. Guo, Yue Cao, 2020, Pharmacological research.